Babies born to anaemic mothers have smaller brains, study finds

Billy Odell Tucker-Robinson Founder & Host — Banking With Billy Network • Intelligence Network • Data Science • AI Research • World News
Published: 2026-09-09T04:20:54.174Z • Permanent link

Research published in a recent study by the University of California, Los Angeles (UCLA), has revealed that babies born to mothers with anaemia have smaller brains, particularly in key regions linked to movement, learning, and emotions. The findings, which were based on data from over 1,000 mothers in the United States, have significant implications for maternal healthcare and neonatal care. The study, which was led by Dr. Jennifer Chang, a renowned expert in perinatal health, used advanced imaging techniques to compare the brain development of babies born to mothers with anaemia to those born to mothers without anaemia.

The research focused on the effects of anaemia on fetal brain development, with particular attention to the impact on the prefrontal cortex, a region critical for executive function, decision-making, and social behavior. The study found that babies born to mothers with severe anaemia were more likely to have smaller brains and reduced cortical thickness in the prefrontal cortex. These findings have important implications for the development of new treatments and interventions aimed at improving fetal brain development in high-risk pregnancies.

The study's findings are also significant because they highlight the critical role that maternal health plays in shaping fetal brain development. Anaemia is a common condition that affects millions of women worldwide, particularly in low- and middle-income countries. The study's lead author, Dr. Chang, emphasized the importance of addressing anaemia in pregnancy, stating, "Our findings underscore the need for better access to prenatal care and iron supplementation for women at risk of anaemia, in order to support healthy fetal brain development.

The research has significant implications for the data sources domain, particularly for companies and research institutions that work in the areas of maternal healthcare, neonatal care, and fetal brain development. Companies such as Johnson & Johnson, Pfizer, and Merck & Co. have developed a range of products and treatments aimed at supporting fetal brain development, including prenatal vitamins, iron supplements, and medications to treat anaemia. The study's findings are likely to have a significant impact on these companies' product development and marketing strategies.

Furthermore, the research has important implications for research communities working in the areas of perinatal health and fetal brain development. The study's findings are likely to inform the development of new research questions and hypotheses, and may lead to the development of new research designs and methodologies aimed at understanding the effects of anaemia on fetal brain development. The study's findings are also likely to inform policy decisions related to maternal healthcare and neonatal care, with potential implications for funding priorities and resource allocation.

The study's findings are part of a larger pattern of research on the effects of maternal health on fetal brain development. In recent years, there has been a growing recognition of the critical role that maternal health plays in shaping fetal brain development, with research highlighting the importance of factors such as nutrition, socioeconomic status, and access to prenatal care. The study's findings are also consistent with previous research on the effects of anaemia on fetal brain development, which has highlighted the need for better access to prenatal care and iron supplementation for women at risk of anaemia.